PATENT CLAIM ANALYSIS

Application Number: 15776548
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "260100"]

Abstract:
A compound or a salt thereof represented by Formula (I). An LSD1 inhibitor containing the compound or a salt thereof as an active ingredient. A pharmaceutical composition containing the compound or salt thereof. An antitumor agent containing the compound or a salt thereof as an active ingredient.

Claim (Index 9):
The pharmaceutical composition according to  claim 8 , in combination with a carrier suitable for oral administration.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 2.03846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10975524', '14107043', '15194980', '15403741', '15688089']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7794790676843831
- 35 USC 102 Novelty (BERT): 0.5327722723843998
- Combined Prediction Score: 0.7548083881543848
- Mean Citation Score: 331.224132
- Max Citation Score: 342.7141
- Similarity Product: 205.8937786211848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test